StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic diabetes Portfolio (Consolidated Segment) — Emerging Markets Organic Growth (Legacy through FY2024Q4, %) (%)

Medtronic Form 8-K Geographic Revenue Tables (FY2016–FY2024)

QuarterlyAnnual
Latest, Q4 FY24
23.2%
Period ended Apr 30, 2024
Change on a year earlier
+18.1 pts
5.1% in Q4 FY23
History
31 quarters
Since Q3 FY16
Sources
31
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiabetes Portfolio (Consolidated Segment) — Emerging Markets Organic Growth (Legacy through FY2024Q4, %) (%)Year on yearSource
Q4 FY24Apr 30, 202423.2%+18.1 ptsMedtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗
Q3 FY24Jan 31, 202418.8%-1.8 ptsMedtronic SEC 8K_EARNINGS — FY2024Q3 (filed 2024-02-20) ↗
Q2 FY24Oct 31, 202314.9%+1.9 ptsMedtronic SEC 8K_EARNINGS — FY2024Q2 (filed 2023-11-21) ↗
Q1 FY24Jul 31, 20236.9%-7.4 ptsMedtronic SEC 8K_EARNINGS — FY2024Q1 (filed 2023-08-22) ↗
Q4 FY23Apr 30, 20235.1%-14.0 ptsMedtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q3 FY23Jan 31, 202320.6%-4.9 ptsMedtronic SEC 8K_EARNINGS — FY2023Q3 (filed 2023-02-21) ↗
Q2 FY23Oct 31, 202213.0%-20.3 ptsMedtronic SEC 8K_EARNINGS — FY2023Q2 (filed 2022-11-22) ↗
Q1 FY23Jul 31, 202214.3%-10.7 ptsMedtronic SEC 8K_EARNINGS — FY2023Q1 (filed 2022-08-23) ↗
Q4 FY22Apr 30, 202219.1%-24.7 ptsMedtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗
Q3 FY22Jan 31, 202225.5%+33.4 ptsMedtronic SEC 8K_EARNINGS — FY2022Q3 (filed 2022-02-22) ↗
Q2 FY22Oct 31, 202133.3%+40.1 ptsMedtronic SEC 8K_EARNINGS — FY2022Q2 (filed 2021-11-23) ↗
Q1 FY22Jul 31, 202125.0%+28.6 ptsMedtronic SEC 8K_EARNINGS — FY2022Q1 (filed 2021-08-24) ↗
Q4 FY21Apr 30, 202143.8%+57.1 ptsMedtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗
Q3 FY21Jan 31, 2021-7.9%-38.5 ptsMedtronic SEC 8K_EARNINGS — FY2021Q3 (filed 2021-02-23) ↗
Q2 FY21Oct 31, 2020-6.8%-39.4 ptsMedtronic SEC 8K_EARNINGS — FY2021Q2 (filed 2020-11-24) ↗
Q1 FY21Jul 31, 2020-3.6%-60.6 ptsMedtronic SEC 8K_EARNINGS — FY2021Q1 (filed 2020-08-25) ↗

Cite this data

StockData. (2026). Medtronic Diabetes Portfolio (Consolidated Segment) — Emerging Markets Organic Growth (Legacy through FY2024Q4, %) (%), quarterly Q3 FY16–Q4 FY24 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/diab-seg-em-leg-org

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.